L'Oreal USA Inc.
Division of L'Oreal SA
Latest From L'Oreal USA Inc.
Plaintiff Claims Against Beiersdorf For ‘Unlawfully Marketed Drug’ Are Preempted By FDCA, Court Rules
After five and a half years, three dismissal motions and one appeal, Beiersdorf’s prevailed on 15 April by summary judgment in a proposed class action alleging that its Nivea Skin Firming Hydration Body Lotion is an unlawfully marketed drug. Of course, the plaintiff still could appeal.
Class Action Watch: Plaintiffs Target L’Oreal’s Pump-Dispensed Liquid Cosmetics, GNC’s Vitamin E Oil
According to a class action complaint filed in California’s Northern District, L’Oreal shortchanges consumers by packaging liquid makeup offerings so that users cannot access significant amounts of product. Meanwhile, the authenticity of GNC’s Vitamin E Skin Oil is being challenged in another California federal court, and Unilever ducks a class action in Texas concerning mercury in Pond’s Rejuveness.
Beiersdorf’s Long Court Battle Over Nivea ‘Drug’ Claims May Be Ending; In Similar Case, L’Oreal May Settle
The Beiersdorf and L’Oreal cases, both pending in California federal courts, have important implications for the cosmetics industry and its use of benefit claims that test statutory boundaries between unapproved drug products and cosmetics.
Energybits' position in a contentious National Advertising Division review and subsequent appeal suggests a failure to grasp marketers’ responsibilities when using health claims for food or dietary supplement products, according to a National Advertising Review Board panel. Energybits maintains the decisions amount to bullying of a small company with ample support for its claims.